← Leaderboards
Gerald W. Dorn
Washington University
$42,039,718
Attributed
$44,051,008
Total exposure
22
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$64,237,252 · 24
By mechanism
P50$30,029,525 · 8
R01$17,645,737 · 7
R35$8,553,650 · 2
R42$3,915,859 · 2
RC2$1,905,001 · 1
P01$957,838 · 1
Top collaborators
- Richard N Kitsis6 shared
- Deborah Ann Hauger2 shared
Most similar at Washington University
Same institution · by research overlap
- Michael K Pasque$4,997,232
- D Woodrow Benson$5,961,180
- Raphael Kopan$20,356,847
- Robert Daniel Rifkin$371,296
- William J Powers$13,261,590
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailureCardiacHeartBaseGeneticIn VivoCardiac MyocytesMediatingSignal TransductionCellsMitochondriaGenesProteinsMouse ModelHeart DiseasesProgramsApoptosisPhysiologicalAdultPathway InteractionsIn VitroMyocardialHypertrophyMolecular
Grant awards (106)
Mitofusin 2 as a Nodal Regulator of Mitochondrial Function in Cardiomyopathy$951,300
R35 · FY2025 · HL · contact PI
Mitofusin 2 as a Nodal Regulator of Mitochondrial Function in Cardiomyopathy$108,850
R35 · FY2025 · HL · contact PI
Mitofusin 2 as a Nodal Regulator of Mitochondrial Function in Cardiomyopathy$1,088,500
R35 · FY2024 · HL · contact PI
Mitofusin Agonists to Treat Neurodegenerative Disease$986,168
R42 · FY2023 · NS
THE MITOCHONDRIAL DYNAMISM/FITNESS/BIOGENESIS INTERACTOME IN CARDIAC DISEASE$915,000
R35 · FY2023 · HL · contact PI
Mitofusin Agonists to Treat Neurodegenerative Disease$968,715
R42 · FY2022 · NS
THE MITOCHONDRIAL DYNAMISM/FITNESS/BIOGENESIS INTERACTOME IN CARDIAC DISEASE$915,000
R35 · FY2022 · HL · contact PI
Mitofusin agonists to prevent Charcot-Marie-Tooth disease 2A$901,762
R42 · FY2022 · NS · contact PI
Mitofusin agonists to prevent Charcot-Marie-Tooth disease 2A$1,059,214
R42 · FY2021 · NS · contact PI
THE MITOCHONDRIAL DYNAMISM/FITNESS/BIOGENESIS INTERACTOME IN CARDIAC DISEASE$915,000
R35 · FY2021 · HL · contact PI
MITOFUSIN AGONISTS TO TREAT NEURODEGENERATIVE DISEASE$78,500
R41 · FY2021 · NS · contact PI
THE MITOCHONDRIAL DYNAMISM/FITNESS/BIOGENESIS INTERACTOME IN CARDIAC DISEASE$915,000
R35 · FY2020 · HL · contact PI
MITOFUSIN AGONISTS TO TREAT NEURODEGENERATIVE DISEASE$224,701
R41 · FY2020 · NS · contact PI
THE MITOCHONDRIAL DYNAMISM/FITNESS/BIOGENESIS INTERACTOME IN CARDIAC DISEASE$915,000
R35 · FY2019 · HL · contact PI
Mitofusin agonists to prevent Charcot-Marie-Tooth disease 2A$254,379
R41 · FY2019 · NS · contact PI
MITOFUSIN AGONISTS TO TREAT NEURODEGENERATIVE DISEASE$254,062
R41 · FY2019 · NS · contact PI
THE MITOCHONDRIAL DYNAMISM/FITNESS/BIOGENESIS INTERACTOME IN CARDIAC DISEASE$915,000
R35 · FY2018 · HL · contact PI
Linking cell death and mitochondrial quality control mechanisms in heart disease$369,856
R01 · FY2018 · HL
Linking cell death and mitochondrial quality control mechanisms in heart disease$136,318
R01 · FY2018 · HL
THE MITOCHONDRIAL DYNAMISM/FITNESS/BIOGENESIS INTERACTOME IN CARDIAC DISEASE$915,000
R35 · FY2017 · HL · contact PI
Linking cell death and mitochondrial quality control mechanisms in heart disease$510,624
R01 · FY2017 · HL
Linking cell death and mitochondrial quality control mechanisms in heart disease$514,961
R01 · FY2016 · HL
G-PROTEIN-DEPENDENT AND -INDEPENDENT KINASE SIGNALING IN CARDIAC HYPERTROPHY$448,826
R01 · FY2016 · HL · contact PI
MOLECULAR ORCHESTRATION OF MITOCHONDRIAL FITNESS VIA REPLACEMENT OR REPAIR$381,250
R01 · FY2016 · HL · contact PI
MITOCHONDRIAL FUSION FACTORS AND CARDIOMYOPATHY$380,000
R01 · FY2016 · HL · contact PI
G-PROTEIN-DEPENDENT AND -INDEPENDENT KINASE SIGNALING IN CARDIAC HYPERTROPHY$442,095
R01 · FY2015 · HL · contact PI
MICRORNA TARGETING IN HEART FAILURE$374,300
R01 · FY2015 · HL · contact PI
MITOCHONDRIAL FUSION FACTORS AND CARDIOMYOPATHY$374,300
R01 · FY2015 · HL · contact PI
Linking cell death and mitochondrial quality control mechanisms in heart disease$267,969
R01 · FY2015 · HL
Linking cell death and mitochondrial quality control mechanisms in heart disease$267,969
R01 · FY2015 · HL
G-PROTEIN-DEPENDENT AND -INDEPENDENT KINASE SIGNALING IN CARDIAC HYPERTROPHY$439,848
R01 · FY2014 · HL · contact PI
MICRORNA TARGETING IN HEART FAILURE$372,400
R01 · FY2014 · HL · contact PI
MITOCHONDRIAL FUSION FACTORS AND CARDIOMYOPATHY$372,400
R01 · FY2014 · HL · contact PI
G-PROTEIN-DEPENDENT AND -INDEPENDENT KINASE SIGNALING IN CARDIAC HYPERTROPHY$448,826
R01 · FY2013 · HL · contact PI
MITOCHONDRIAL FUSION FACTORS AND CARDIOMYOPATHY$361,760
R01 · FY2013 · HL · contact PI
MICRORNA TARGETING IN HEART FAILURE$361,760
R01 · FY2013 · HL · contact PI
MICRORNA TARGETING IN HEART FAILURE$380,000
R01 · FY2012 · HL · contact PI
Molecular Mechanism of Apoptotic Cardiomyopathy$376,200
R01 · FY2012 · HL · contact PI
MITOCHONDRIAL MANIPULATION AND ANALYSIS IN DROSOPHILA HEARTS$190,000
R21 · FY2012 · HL · contact PI
G-Protein Receptor Kinases in Cardiac Stress Adaptation$472,659
R01 · FY2011 · HL · contact PI
Molecular Mechanism of Apoptotic Cardiomyopathy$380,000
R01 · FY2011 · HL · contact PI
MITOCHONDRIAL MANIPULATION AND ANALYSIS IN DROSOPHILA HEARTS$228,000
R21 · FY2011 · HL · contact PI
CTRIP: Genetic Testing to Individualize Management of Common Heart Diseases$943,853
RC2 · FY2010 · HL · contact PI
G-Protein Receptor Kinases in Cardiac Stress Adaptation$477,434
R01 · FY2010 · HL · contact PI
Molecular Mechanism of Apoptotic Cardiomyopathy$380,000
R01 · FY2010 · HL · contact PI
Calpains as Mediators of Cardiac Ischemic Injury$368,980
R01 · FY2010 · HL · contact PI
CTRIP: Genetic Testing to Individualize Management of Common Heart Diseases$961,148
RC2 · FY2009 · HL · contact PI
Core--Heart Failure Genomics$642,469
P50 · FY2009 · HL · contact PI
A-Adrenergic Axis in Hypertrophy and Heart Failure$629,961
P50 · FY2009 · HL · contact PI
G-Protein Receptor Kinases in Cardiac Stress Adaptation$475,144
R01 · FY2009 · HL · contact PI
Core--Embryonic Stem Cell Gene Manipulation$464,303
P50 · FY2009 · HL · contact PI
Molecular Mechanism of Apoptotic Cardiomyopathy$380,000
R01 · FY2009 · HL · contact PI
Calpains as Mediators of Cardiac Ischemic Injury$368,980
R01 · FY2009 · HL · contact PI
Core--Clinical Research Skills Development$145,989
P50 · FY2009 · HL · contact PI
Core--Heart Failure Genomics$613,684
P50 · FY2008 · HL · contact PI
A-Adrenergic Axis in Hypertrophy and Heart Failure$603,331
P50 · FY2008 · HL · contact PI
G-Protein Receptor Kinases in Cardiac Stress Adaptation$463,472
R01 · FY2008 · HL · contact PI
Core--Embryonic Stem Cell Gene Manipulation$442,285
P50 · FY2008 · HL · contact PI
Molecular Mechanism of Apoptotic Cardiomyopathy$380,000
R01 · FY2008 · HL · contact PI
Calpains as Mediators of Cardiac Ischemic Injury$368,980
R01 · FY2008 · HL · contact PI
Core--Clinical Research Skills Development$139,420
P50 · FY2008 · HL · contact PI
Genetic and Molecular Signaling in Heart Failure$3,762,510
P50 · FY2007 · HL · contact PI
Core--Heart Failure Genomics$610,426
P50 · FY2007 · HL · contact PI
A-Adrenergic Axis in Hypertrophy and Heart Failure$601,743
P50 · FY2007 · HL · contact PI
Core--Embryonic Stem Cell Gene Manipulation$438,699
P50 · FY2007 · HL · contact PI
G-Protein Receptor Kinases in Cardiac Stress Adaptation$303,505
R01 · FY2007 · HL · contact PI
Calpains as Mediators of Cardiac Ischemic Injury$210,942
R01 · FY2007 · HL · contact PI
Calpains as Mediators of Cardiac Ischemic Injury$161,679
R01 · FY2007 · HL · contact PI
G-Protein Receptor Kinases in Cardiac Stress Adaptation$156,594
R01 · FY2007 · HL · contact PI
Core--Clinical Research Skills Development$138,634
P50 · FY2007 · HL · contact PI
Genetic and Molecular Signaling in Heart Failure$3,767,826
P50 · FY2006 · HL · contact PI
Core--Heart Failure Genomics$604,291
P50 · FY2006 · HL · contact PI
A-Adrenergic Axis in Hypertrophy and Heart Failure$596,796
P50 · FY2006 · HL · contact PI
Core--Embryonic Stem Cell Gene Manipulation$432,896
P50 · FY2006 · HL · contact PI
Calpains as Mediators of Cardiac Ischemic Injury$383,750
R01 · FY2006 · HL · contact PI
RAB GTPase protein transport regulation in heart disease$329,030
P01 · FY2006 · HL · contact PI
Molecular Mechanism of Apoptotic Cardiomyopathy$298,077
R01 · FY2006 · HL · contact PI
Core--Clinical Research Skills Development$136,967
P50 · FY2006 · HL · contact PI
Genetic and Molecular Signaling in Heart Failure$3,830,617
P50 · FY2005 · HL
Core--Heart Failure Genomics$600,064
P50 · FY2005 · HL
A-Adrenergic Axis in Hypertrophy and Heart Failure$592,789
P50 · FY2005 · HL
PHOSPHOLIPASE C AND CARDIAC HYPERTROPHY$429,914
R01 · FY2005 · HL
Core--Embryonic Stem Cell Gene Manipulation$420,288
P50 · FY2005 · HL
RAB GTPase protein transport regulation in heart disease$322,833
P01 · FY2005 · HL
Molecular Mechanism of Apoptotic Cardiomyopathy$305,250
R01 · FY2005 · HL
Core--Clinical Research Skills Development$132,977
P50 · FY2005 · HL
Administrative Core$122,969
P50 · FY2005 · HL
SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE$1,846,147
P50 · FY2004 · HL
PHOSPHOLIPASE C AND CARDIAC HYPERTROPHY$417,392
R01 · FY2004 · HL
Molecular Mechanism of Apoptotic Cardiomyopathy$305,250
R01 · FY2004 · HL
SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE$1,805,950
P50 · FY2003 · HL
PHOSPHOLIPASE C AND CARDIAC HYPERTROPHY$405,233
R01 · FY2003 · HL
Molecular Mechanism of Apoptotic Cardiomyopathy$318,625
R01 · FY2003 · HL
SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE$1,763,311
P50 · FY2002 · HL
PHOSPHOLIPASE C AND CARDIAC HYPERTROPHY$406,679
R01 · FY2002 · HL
RAB GTPase protein transport regulation in heart disease$305,975
P01 · FY2002 · HL
MOLECULAR MECHANISM OF APOPTOTIC CARDIOMYOPATHY$280,558
R01 · FY2002 · HL
PKC signaling in cardiac adaptation and maladaption$244,100
P50 · FY2002 · HL
SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE$1,701,183
P50 · FY2001 · HL
PHOSPHOLIPASE C AND CARDIAC HYPERTROPHY$275,331
R01 · FY2001 · HL
MOLECULAR MECHANISM OF APOPTOTIC CARDIOMYOPATHY$273,807
R01 · FY2001 · HL
PKC signaling in cardiac adaptation and maladaption$244,100
P50 · FY2001 · HL
SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE$1,708,700
P50 · FY2000 · HL
PHOSPHOLIPASE C AND CARDIAC HYPERTROPHY$348,586
R01 · FY2000 · HL
MOLECULAR MECHANISM OF APOPTOTIC CARDIOMYOPATHY$267,254
R01 · FY2000 · HL
PKC signaling in cardiac adaptation and maladaption$244,100
P50 · FY2000 · HL